AKAN$10.5+223.08% |
Akanda Corp. (AKAN) is experiencing a drastic fluctuation today, with its stock surging over 200%, primarily driven by a potent combination of a recent reverse stock split and broader positive news within the cannabis sector. The company implemented a 1-for-4.5 reverse stock split, effective April 13, 2026. This action, approved by shareholders in November 2025 and the board in March 2026, significantly reduced the number of outstanding common shares from approximately 2.4 million to about 534,400. |
AGPU$8.67+77.66% |
Axe Compute Inc. (AGPU) experienced a dramatic surge in its stock price today, jumping nearly 96% to over 140% in pre-market trading, primarily driven by the announcement of a substantial 36-month enterprise infrastructure contract valued at approximately $260 million. This deal, which represents the largest enterprise engagement in the company's history, involves delivering a dedicated cluster of 2,304 NVIDIA B300 GPUs and AI-focused high-speed storage. |
TORO$6.79+73.66% |
Toro Corp. (NASDAQ: TORO), a global energy transportation provider specializing in oceangoing tanker vessels, experienced significant volatility today primarily due to its announcement of a one-time special dividend. On April 22, 2026, the company declared a special dividend of $0.90 per common share, which shareholders can elect to receive in either cash or company stock. This substantial payout, relative to its stock price, has clearly spurred strong investor interest and driven the stock's sharp upward movement. |
ELPW$2.54+61.78% |
Elong Power (ELPW) experienced a significant surge today, primarily driven by technical and speculative momentum stemming from its extremely low share float and recent corporate actions. The company recently executed a substantial 1-for-80 reverse stock split, effective March 12, 2026, which drastically reduced its outstanding shares and public float to approximately 1.4 million. This action was primarily undertaken to regain compliance with Nasdaq's minimum bid price requirement. |
XNDU$33.91+48.08% |
Xanadu Quantum Technologies (XNDU) experienced significant volatility today, primarily driven by a recalibration of speculative market sentiment following a recent surge. The stock's dramatic run-up earlier this month was largely fueled by Nvidia's announcement of new open-source AI models for quantum computing around April 16, 2026. This sparked sector-wide enthusiasm, positioning XNDU, a photonics-based quantum computing firm, as a beneficiary of the broader AI and quantum hype, leading its stock price to nearly triple in a week. |
HCAI$9.5+39.91% |
Huachen AI (HCAI) is experiencing significant volatility today, with its stock price increasing by 11.78% and fluctuating by 34.02% on April 22, 2026. This sharp movement is primarily driven by a confluence of recent corporate actions and regulatory concerns, creating an extremely speculative trading environment. |
GNLN$5.47+39.31% |
GNLN's significant positive fluctuation today, April 22, 2026, is primarily attributable to the recent announcement regarding a pre-funded warrant conversion and a lock-up agreement for strategic advisor warrants. On April 21, Greenlane Holdings announced that Berachain Investment Corporation (BIC) would convert 33,085 pre-funded warrants into Class A common stock, carefully maintaining a 4.99% beneficial ownership limit to avoid triggering additional shareholder approval requirements. More importantly, holders of 162,760 Strategic Advisor Warrants committed to a lock-up until April 23, 2027, significantly reducing near-term selling pressure and potential market dilution from these shares. This dual news event was met with a "significant positive market reaction," with GNLN gaining 19.59% following the announcement. |
INBX$114.13+35.74% |
Inhibrx (INBX) stock experienced a substantial surge today, driven primarily by strong acquisition interest from major pharmaceutical companies and highly positive clinical trial data for its cancer drug pipeline. Reuters reported that large drugmakers, including Merck & Co., Merck KGaA, and Ono Pharmaceutical, are eyeing Inhibrx's experimental cancer therapies, notably INBRX-106 and ozekibart (INBRX-109), with a potential deal value exceeding $8 billion. This M&A speculation acts as a significant catalyst, signaling potential lucrative returns for shareholders. |
BEEM$1.98+30.26% |
Beam Global (NASDAQ: BEEM) experienced a significant surge in its stock price today, April 22, 2026, with shares increasing by approximately 25-28%. This substantial upward movement is primarily attributed to a positive news announcement released on April 21, 2026. The company declared the deployment of ten EV ARC™ off-grid, solar-powered electric vehicle charging systems and an ARC Mobility™ trailer for Stanislaus County, California, directly addressing the provided headline. This contract highlights BEEM's ongoing success in securing significant orders for its sustainable infrastructure solutions, reinforcing its position in the rapidly expanding clean-technology sector. |
NMAX$9.43+29.53% |
Newsmax Inc. Class B (NMAX) shares experienced a significant surge today, climbing over 35%. The primary catalyst appears to be a massive spike in call option volume, with investors purchasing 13,430 call options, a remarkable 1,505% increase over typical daily volume, indicating substantial bullish sentiment or speculative "meme stock" interest. |